13. december · npinvestor.dk
The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S
Thomas Kaas Selsø, adm. direktør i Pharma Equity Group A/S, telefon:
Læs artikel
Beløb i DKK 1.000 | 2023 | 2022 |
---|---|---|
Bruttofortjeneste | 0 | – |
Årets resultat | -24.609 | 3.479 |
Aktiver i alt | 81.335 | 71.072 |
Egenkapital | 38.931 | 46.045 |